ArticleClinical hypertension2019
2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations.
Article in Clinical hypertension, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Information technology-supported integrated health service for older adults in long-term care settings.BMC medicine · 2024Trial
- Cardiovascular Risk Factor Prevalence and Control by Education Strata in Older Adults in 3 Countries.JAMA network open · 2026Article
- Evaluation of guideline adherence to hypertension-mediated organ damage screening in Korean patients with hypertension: results from the Korean Registry of Target Organ Damage in Hypertension (KorHR).Clinical hypertension · 2026Article
- Update of the Korean Clinical Practice Guidelines for Stroke: Blood Pressure Management.Journal of clinical neurology (Seoul, Korea) · 2025Review
- Managing Hypertension in Chronic Kidney Disease: The Role of Diet and Guideline Recommendations.Journal of clinical medicine · 2025Review
- Korea Hypertension Fact Sheet 2023: analysis of nationwide population-based data with a particular focus on hypertension in special populations.Clinical hypertension · 2024Article
- Sex differences in the applicability of Western cardiovascular disease risk prediction equations in the Asian population.PloS one · 2024Article
- Diagnosis and treatment of hypertension in dialysis patients: a systematic review.Clinical hypertension · 2023Review
- Sex and gender in hypertension guidelines.Journal of human hypertension · 2023Review
- Suboptimal control status of young hypertensive population.Clinical hypertension · 2023Review
- Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum.Clinical hypertension · 2022Review
- A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective.Clinical hypertension · 2022Review
- Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients.The Korean journal of internal medicine · 2022Article
- Safety, efficacy and delivery of isometric resistance training as an adjunct therapy for blood pressure control: a modified Delphi study.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Article
- Blood pressure and mortality after percutaneous coronary intervention: a population-based cohort study.Scientific reports · 2022Article
- Appraisal of Guidelines for the Management of Blood Pressure in Patients with Diabetes Mellitus: The Consensuses, Controversies and Gaps.Diabetes & metabolism journal · 2021Article
- Large Artery Stiffness: A Companion to the 2015 AHA Science Statement on Arterial Stiffness.Pulse (Basel, Switzerland) · 2021Review
- Development of a Korean-specific cardiovascular risk model in a cohort at high-risk of hypertension.The Korean journal of internal medicine · 2021Article
- Suboptimal Management Status of Younger Hypertensive Population in Korea.Korean circulation journal · 2021Article
- How We Got Where We Are in Blood Pressure Targets.Current hypertension reports · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients' characteristics. Additionally, the target blood pressure or initial drug choice should be customized according to the special conditions of the hypertensive patients. In this part III, we reviewed previous data and presented recommendations for some special populations such as diabetes mellitus, chronic kidney disease, elderly people, and cardio-cerebrovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.